Wedbush Upgrades Unum Therapeutics (UMRX) to Outperform

July 7, 2020 6:22 AM EDT
Get Alerts UMRX Hot Sheet
Price: $2.35 --0%

Rating Summary:
    4 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

Wedbush analyst David Nierengarten upgraded Unum Therapeutics (NASDAQ: UMRX) from Neutral to Outperform with a price target of $4.00 (from $1.00).

For an analyst ratings summary and ratings history on Unum Therapeutics click here. For more ratings news on Unum Therapeutics click here.

Shares of Unum Therapeutics closed at $2.02 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Upgrades